196 related articles for article (PubMed ID: 33772427)
1. A tumor-promoting role for soluble TβRIII in glioblastoma.
Burghardt I; Schroeder JJ; Weiss T; Gramatzki D; Weller M
Mol Cell Biochem; 2021 Aug; 476(8):2963-2973. PubMed ID: 33772427
[TBL] [Abstract][Full Text] [Related]
2. Type III TGF-β receptor enhances colon cancer cell migration and anchorage-independent growth.
Gatza CE; Holtzhausen A; Kirkbride KC; Morton A; Gatza ML; Datto MB; Blobe GC
Neoplasia; 2011 Aug; 13(8):758-70. PubMed ID: 21847367
[TBL] [Abstract][Full Text] [Related]
3. The balance of cell surface and soluble type III TGF-β receptor regulates BMP signaling in normal and cancerous mammary epithelial cells.
Gatza CE; Elderbroom JL; Oh SY; Starr MD; Nixon AB; Blobe GC
Neoplasia; 2014 Jun; 16(6):489-500. PubMed ID: 25077702
[TBL] [Abstract][Full Text] [Related]
4. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.
Gordon KJ; Dong M; Chislock EM; Fields TA; Blobe GC
Carcinogenesis; 2008 Feb; 29(2):252-62. PubMed ID: 17999987
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma.
Seystahl K; Tritschler I; Szabo E; Tabatabai G; Weller M
Neuro Oncol; 2015 Feb; 17(2):254-65. PubMed ID: 25165192
[TBL] [Abstract][Full Text] [Related]
6. Epithelial membrane protein 3 regulates TGF-β signaling activation in CD44-high glioblastoma.
Jun F; Hong J; Liu Q; Guo Y; Liao Y; Huang J; Wen S; Shen L
Oncotarget; 2017 Feb; 8(9):14343-14358. PubMed ID: 27527869
[TBL] [Abstract][Full Text] [Related]
7. Ectodomain shedding of TβRIII is required for TβRIII-mediated suppression of TGF-β signaling and breast cancer migration and invasion.
Elderbroom JL; Huang JJ; Gatza CE; Chen J; How T; Starr M; Nixon AB; Blobe GC
Mol Biol Cell; 2014 Aug; 25(16):2320-32. PubMed ID: 24966170
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of the type III TGF-β receptor enhances metastasis and invasion in hepatocellullar carcinoma progression.
Zhang S; Sun WY; Wu JJ; Gu YJ; Wei W
Oncol Rep; 2016 Apr; 35(4):2373-81. PubMed ID: 26882862
[TBL] [Abstract][Full Text] [Related]
9. USP15 stabilizes TGF-β receptor I and promotes oncogenesis through the activation of TGF-β signaling in glioblastoma.
Eichhorn PJ; Rodón L; Gonzàlez-Juncà A; Dirac A; Gili M; Martínez-Sáez E; Aura C; Barba I; Peg V; Prat A; Cuartas I; Jimenez J; García-Dorado D; Sahuquillo J; Bernards R; Baselga J; Seoane J
Nat Med; 2012 Feb; 18(3):429-35. PubMed ID: 22344298
[TBL] [Abstract][Full Text] [Related]
10. Identification of soluble transforming growth factor-beta receptor III (sTbetaIII) in rat milk.
Zhang M; Zola H; Read L; Penttila I
Immunol Cell Biol; 2001 Jun; 79(3):291-7. PubMed ID: 11380683
[TBL] [Abstract][Full Text] [Related]
11. Increased type III TGF-β receptor shedding decreases tumorigenesis through induction of epithelial-to-mesenchymal transition.
Huang JJ; Corona AL; Dunn BP; Cai EM; Prakken JN; Blobe GC
Oncogene; 2019 May; 38(18):3402-3414. PubMed ID: 30643193
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta receptor type III is a tumor promoter in mesenchymal-stem like triple negative breast cancer.
Jovanović B; Beeler JS; Pickup MW; Chytil A; Gorska AE; Ashby WJ; Lehmann BD; Zijlstra A; Pietenpol JA; Moses HL
Breast Cancer Res; 2014 Jul; 16(4):R69. PubMed ID: 24985072
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of type III TGF-β receptor aggravates lung fibrotic process.
Ahn JY; Park S; Yun YS; Song JY
Biomed Pharmacother; 2010 Sep; 64(7):472-6. PubMed ID: 20359848
[TBL] [Abstract][Full Text] [Related]
14. The type III TGF-beta receptor suppresses breast cancer progression.
Dong M; How T; Kirkbride KC; Gordon KJ; Lee JD; Hempel N; Kelly P; Moeller BJ; Marks JR; Blobe GC
J Clin Invest; 2007 Jan; 117(1):206-17. PubMed ID: 17160136
[TBL] [Abstract][Full Text] [Related]
15. Loss of type III transforming growth factor-beta receptor expression is due to methylation silencing of the transcription factor GATA3 in renal cell carcinoma.
Cooper SJ; Zou H; Legrand SN; Marlow LA; von Roemeling CA; Radisky DC; Wu KJ; Hempel N; Margulis V; Tun HW; Blobe GC; Wood CG; Copland JA
Oncogene; 2010 May; 29(20):2905-15. PubMed ID: 20208565
[TBL] [Abstract][Full Text] [Related]
16. The type III TGF-beta receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-beta signaling.
Lee JD; Hempel N; Lee NY; Blobe GC
Carcinogenesis; 2010 Feb; 31(2):175-83. PubMed ID: 19955393
[TBL] [Abstract][Full Text] [Related]
17. Type III TGF-β receptor inhibits cell proliferation and migration in salivary glands adenoid cystic carcinoma by suppressing NF-κB signaling.
Xu D; Li D; Lu Z; Dong X; Wang X
Oncol Rep; 2016 Jan; 35(1):267-74. PubMed ID: 26531330
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic Ki-ras confers a more aggressive colon cancer phenotype through modification of transforming growth factor-beta receptor III.
Yan Z; Deng X; Friedman E
J Biol Chem; 2001 Jan; 276(2):1555-63. PubMed ID: 11029459
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptor.
Kirkbride KC; Townsend TA; Bruinsma MW; Barnett JV; Blobe GC
J Biol Chem; 2008 Mar; 283(12):7628-37. PubMed ID: 18184661
[TBL] [Abstract][Full Text] [Related]
20. TβRIII independently binds type I and type II TGF-β receptors to inhibit TGF-β signaling.
Tazat K; Hector-Greene M; Blobe GC; Henis YI
Mol Biol Cell; 2015 Oct; 26(19):3535-45. PubMed ID: 26269580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]